Expression of PD-L1 and BCG immunotherapy in non-muscle invasive bladder cancer

被引：2
|
作者：
Heo, Jun Hyeok
Jin, Hyun A.
Kang, You Hyun
Kim, Ki Hong
Hong, Sung Joon
Han, Kyung Seok
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.TME16-A16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A16
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer
    Zucca, Luis Eduardo Rosa
    Laus, Ana Carolina
    Sorroche, Bruna Pereira
    Paro, Eduarda
    Sussuchi, Luciane
    Marques, Rui Ferreira
    Teixeira, Gustavo Ramos
    Berardinelli, Gustavo Noriz
    Arantes, Lidia Maria Rebolho Batista
    Reis, Rui Manuel
    Carcano, Flavio Mavignier
    TRANSLATIONAL ONCOLOGY, 2024, 46
  • [32] Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor
    Vandeveer, Amanda J.
    Fallon, Jonathan K.
    Tighe, Robert
    Sabzevari, Helen
    Schlom, Jeffrey
    Greiner, John W.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (05) : 452 - 462
  • [33] PD-L1 as a potential biomarker in high grade non muscle invasive bladder cancer
    Gandara Cortes, M.
    Castro-Iglesias, A. M.
    Gomez de Maria, C.
    Antunez, J. R.
    Garcia-Caballero, T.
    Lopez Diez, E.
    Ortiz Rey, J. A.
    San Miguel Fraile, M. P.
    VIRCHOWS ARCHIV, 2020, 477 : S159 - S160
  • [34] Re: Analysis of Age Influence on Oncological Results and Toxicity of BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2022, 207 (04): : 927 - 928
  • [35] Hyperthermic intravesical chemotherapy for BCG unresponsive or BCG ineligible non-muscle invasive bladder cancer
    de Jong, Joep J.
    Rosier, Marloes
    Boormans, Joost L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 613 - 613
  • [36] BLADDER CANCER PD-L1 and BCG response prediction
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2020, 17 (01) : 8 - 8
  • [37] Current advances in BCG-unresponsive non-muscle invasive bladder cancer
    Tse, Jennifer
    Singla, Nirmish
    Ghandour, Rashed
    Lotan, Yair
    Margulis, Vitaly
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) : 757 - 770
  • [38] BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
    Guerrero-Ramos, F.
    ACTAS UROLOGICAS ESPANOLAS, 2023, 47 (06): : 329 - 331
  • [39] TUMOR MICROBIOME ASSOCIATED WITH BCG RESPONSE IN NON-MUSCLE INVASIVE BLADDER CANCER
    Knorr, Jacob
    Adler, Ava
    Agudelo, Jose
    Ericson, Kyle
    Murthy, Prithvi
    Campbell, Rebecca
    Bajic, Petar
    Almassi, Nima
    Weight, Christopher
    Haber, Georges-Pascal
    Miller, Aaron
    Lee, Byron
    JOURNAL OF UROLOGY, 2021, 206 : E725 - E726
  • [40] Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer
    Smaldone, M. C.
    Gingrich, J. R.
    MINERVA UROLOGICA E NEFROLOGICA, 2010, 62 (02) : 129 - 132
12345